Team uses AlphaFold AI to redesign gene-editing proteins to make them safer (arstechnica.com)

Researchers have leveraged AlphaFold, an AI protein-folding tool, to enhance the safety of gene-editing proteins by targeting and redesigning components responsible for off-target effects. As gene-editing therapies advance, the potential for unintended edits increases due to the vastness of the human genome. These off-target effects, although rare, can lead to significant issues during treatment, necessitating the need for improved precision in these systems. The study, published in Nature, details how scientists identified critical areas within gene-editing proteins, such as the Cas9 protein used in CRISPR, that contribute to off-target interactions. By modifying these regions, the team aims to reduce the likelihood of erroneous edits. This advancement has broader implications for the AI and ML communities, demonstrating the powerful intersection of artificial intelligence with genetic engineering, potentially paving the way for safer and more effective gene therapies through refined design processes.